| HealthBanks Biotech Co., Ltd. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110027311 | COMBINATION OF PROTEIN VACCINE AND MESENCHYMAL STEM CELLS FOR TREATING CANCER - A method for inhibiting growth and/or metastasis of a tumor in a mammal is disclosed. The method comprises administering to a mammal in need thereof an effective amount of stem cells comprising a transgene encoding at least one oncogenic protein, wherein the stem cells are immortal and show no signs of neoplastic transformation, and administering to the mammal a vaccine composition comprising an effective amount of at least one immunogenic protein capable of eliciting at least one antibody specific against the at least one oncogenic protein, and thereby inhibiting growth and/or metastasis of a tumor in the mammal. A therapeutic kit for inhibiting growth and/or metastasis of a tumor in a mammal is also disclosed. | 02-03-2011 |
| 20100253190 | Storage apparatus for storing products - The present invention relates to a storage apparatus, including: a base; an axle unit, supported on the base; a first storage-access unit and a plurality of storage units of which the bottoms correspond to the base and arranged in a first circle; a plurality of second storage units of which the bottoms correspond to the base and arranged in a second circle; a first rotating unit connected with the tops of the first storage units; a first cover unit connected with the tops of the second storage units; and a plurality of first rolling units connected with the first rotating unit, wherein the first storage-access unit and the first storage units can rotate relative to the second storage units. Accordingly, the storage apparatus of the present invention can be employed in storing and accessing the products independently. | 10-07-2010 |
| 20090203884 | CHIMERIC HIV FUSION PROTEINS AS VACCINES - A chimeric fusion protein useful as an immunogen for inducing HIV antigen-specific immune responses contains a first polypeptidyl region and a second polypeptidyl region. The first polypeptidyl region includes a Pseudomonas Exotoxin A (PE) binding domain and a PE translocation domain. The second polypeptidyl region includes (i) a first peptidyl segment containing a fragment of gp120 C1 domain, located at the N-terminus of the second peptidyl region; (ii) a second peptidyl segment containing a fragment of gp120 C5 domain, located at the C-terminus of the first peptidyl segment; and (iii) a third peptidyl segment containing a fragment of gp41, located at the C-terminus of the second peptidyl segment. The second polypeptidyl region contains an antigenic determinant specific to one subtype of HIV. An intermediate polypeptide containing a non-Env, HIV antigenic determinant selected from Gag24, Nef, Tat and Rev may be included. | 08-13-2009 |
| 20090144494 | Storage-access apparatus for storing products and storage system thereof - A storage-access apparatus includes a first support device including a first base; at least one first storage-access device and at least one first storage device, disposed on the first base and arranged in a first circle; a second support device including a second base; at least one second storage-access device and at least one second storage device, disposed on the second base and arranged in a second circle; and a transporting device, wherein the first storage-access device, the first storage device, the second storage-access device and the second storage device each has plural compartments, the transporting device corresponds to the compartments, and the first storage-access device and the first storage device can rotate relative to the second storage-access device and the second storage device. Accordingly, the storage-access apparatus can be employed in depositing and picking up products independently. Also disclosed is a storage system including, among others, the storage-access apparatus. | 06-04-2009 |
| 20090088556 | FUSION ANTIGEN USED AS VACCINE AND METHOD OF MAKING THEM - Fusion antigen used as vaccine and method of making them. The method includes: (1) selecting a segment of a virus protein sequence that contains a least one epitope; (2) engineering a DNA fragment encoding the selected segment of the virus protein; (3) inserting the DNA fragment into a | 04-02-2009 |
| 20080206271 | FUSION ANTIGEN USED AS VACCINE - Fusion antigen used as vaccine. The invention relates to a fusion antigen specific for a target cell. The fusion antigen contains a ligand moiety, a | 08-28-2008 |
